GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps regulate blood sugar levels Slowing gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger signals and food cravings Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver Most GLP-1 agonists are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation, though oral semaglutide (Rybelsus) is also available
Additionally, there is a boxed warning regarding thyroid C-cell tumors based on rodent studies, though human relevance remains uncertain
When someone loses weight rapidly, basal metabolic ratethe calories burned at restnaturally decreases
la materia prima que usamos es de primera categora
Unlike many people on semaglutide, Wood hasn't experienced any negative side effects, she said